apl. Prof. Dr. Niels Schaft

Medizinische Fakultät Department of Dermatology

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma (2017) Harrer DC, Simon B, Fujii SI, Shimizu K, Uslu U, Schuler G, Gerer KF, et al. Journal article Sarcoidosis Under Dendritic Cell Vaccination Immunotherapy in Long-term Responding Patients with Metastatic Melanoma (2017) Uslu U, Erdmann M, Schliep S, Dörrie J, Schaft N, Schuler G, Schuler-Thurner B Journal article Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination (2017) Gerer KF, Erdmann M, Hadrup SR, Lyngaa R, Martin LM, Voll RE, Schuler-Thurner B, et al. Journal article Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response (2017) Lehmann B, Biburger M, Brückner C, Ipsen Escobedo A, Gordan S, Lehmann C, Vöhringer D, et al. Journal article, Original article Electroporation of mRNA as universal technology platform to transfect a variety of primary cells with antigens and functional proteins (2017) Gerer KF, Hoyer S, Dörrie J, Schaft N Book chapter / Article in edited volumes Autologous whole tumor cell-based vaccines generated with high hydrostatic pressure bear immunogenic potential and act synergistically with radiotherapy to retard tumor growth (2017) Frey B, Seitz C, Weiss EM, Rueckert M, Schlücker E, Schaft N, Fietkau R, Gaipl U Conference contribution CAR/TCR-transfected gamma/delta T cells for immunotherapy of melanoma (2017) Harrer DC, Simon B, Fujii S, Shimizu K, Uslu U, Schoch L, Schuler G, et al. Conference contribution A systems biology approach to characterize the function of miRNAs in dendritic cell-mediated immunogenicity and therapeutic cancer vaccination (2017) Lai X, Dreyer F, Jaitly T, Gerer KF, Schuler G, Dörrie J, Schaft N, Vera J Conference contribution BRAF and MEK inhibitors influence human immune cell phenotype and function (2017) Hoyer S, Eberlein V, Babalija L, Gerer KF, Walter L, Schuler G, Schaft N, et al. Conference contribution The simultaneous siRNA-mediated downregulation of inhibitory receptors to improve CAR-T cell immunotherapy of melanoma (2017) Simon B, Harrer D, Weide B, Schuler G, Schuler-Thurner B, Dörrie J, Schaft N, Uslu U Conference contribution